Author

J. K. Harrison

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

D. A. Mitchell· 2 shared G. P. Takacs· 2 shared G. Tian· 2 shared L. P. Deleyrolle· 2 shared A. Chakraborty· 1 shared A. Silver· 1 shared C. J. Kreiger· 1 shared C. Yang· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. A. Mitchell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system

A. Chakraborty, C. Yang, J. L. Kresak, A. Silver, D. Feier, G. Tian, M. Andrews, O. O. Sobanjo, O. O. Sobanjo, E. D. Hodge, M. K. Engelbart, J. Huang, J. K. Harrison, M. Sarkisian, D. A. Mitchell, L. P. Deleyrolle

This study validates a murine model of glioblastoma stem cells that recapitulate human features and enables investigation of their interactions with the immune system.

bioRxiv · Jan 26, 2024 · PreprintCancer Biology

Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma

H. G. Anderson, G. P. Takacs, D. C. Harris, Y. Kuang, J. K. Harrison, T. L. Stepien

This paper develops a tumor-immune model for glioblastoma, identifies key parameters for treatment, and suggests combining immune checkpoint inhibitors with MDSC-targeting therapies.

bioRxiv · May 15, 2023Cancer Biology

Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+ myeloid cells into the tumor microenvironment in a redundant manner

G. P. Takacs, C. J. Kreiger, D. Luo, G. Tian, J. S. Garcia, L. P. Deleyrolle, D. A. Mitchell, J. K. Harrison

This study shows that CCL2 and CCL7 from gliomas redundantly recruit CCR2+/CX3CR1+ myeloid cells into the tumor microenvironment, contributing to immune suppression and poor prognosis in GBM.

bioRxiv · Jul 8, 2022Cancer Biology